Officials said Friday during a panel discussion — hosted by the FDA and the independent nonprofit Reagan-Udall Foundation for the FDA — that, while new treatments and drug approvals are needed, existing treatments aren’t being used to their full capacity.

To help support implementation, FDA worked with the Reagan-Udall Foundation to host three roundtable discussions on the Food Traceability Rule.

Jones came to the FDA with intimate knowledge of the foods program, having served on the Reagan-Udall Foundation’s Independent Expert Panel, which evaluated it in 2022.